Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
112.69
+0.59 (+0.53%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Lilly Stock Receives Key IBD Stock Rating Upgrade; Looking To Extend Its Long Run Higher
November 04, 2021
Lilly stock's Accumulation/Distribution Rating of B shows moderate buying by institutional investors over the last 13 weeks.
Via
Investor's Business Daily
7 Dividend Aristocrat Stocks That Should Grace Your Portfolio
November 03, 2021
You get a lot more more from dividend aristocrat stocks than just a rock-solid dividend. They also promise solid, long-term growth.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations
November 03, 2021
SOURCE: Abbott
Via
3BL Media
Real Sustainability Is About People
October 29, 2021
SOURCE: Abbott
Via
3BL Media
Vice President Of Abbott Laboratories Makes $1.0M Sale
October 28, 2021
Philip P Boudreau, Vice President at Abbott Laboratories (NYSE:ABT), made a large insider sell on October 25, according to a new SEC filing. What Happened: A Form 4 filing from...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Edwards Topples As Full-Year Guidance Comes In Light After Mixed Quarter
October 27, 2021
The company retained guidance for adjusted profit of $2.07-$2.27, missing the midpoint of analysts' view.
Via
Investor's Business Daily
Where Abbott Laboratories Stands With Analysts
October 27, 2021
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2021
October 27, 2021
Upgrades According to Credit Suisse, the prior rating for Mercer International Inc (NASDAQ:
Via
Benzinga
Got $5,000? These 2 Unstoppable Stocks Are No-Brainer Buys
October 26, 2021
Both are great places to park your money for years.
Via
The Motley Fool
Kimberly-Clark's Earnings Remind Investors that Inflation and Supply Chain Issues are Still a Major Theme
October 25, 2021
This week is a big one for earnings, not just because of the big names reporting but because of the large number of earnings announcements. Investors can expect the themes of...
Via
Benzinga
Will Tech Stocks Derail the 3Q21 Earnings Rally?
October 24, 2021
S&P 500 equities continued to post robust 3rd quarter earnings reports, staying on track to grow EPS by 32.7% year-over-year. Over 84% of those reporting topped analysts’ forecasts. The damage from a...
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
AbbVie: A Healthy Idea For Retirement Portfolios
October 23, 2021
The healthcare industry is among the cheapest sectors in today's market, and this pandemic has validated its importance for the economy and our overall well-being. Over the next decade, we will see...
Via
Talk Markets
Topics
Economy
Retirement
Exposures
Economy
Pension
A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO
October 22, 2021
Key takeaways Four rounds of fundraising together with IPO proceeds have given the Abbisko a cumulative war chest of almost $500 million Company is betting a significant portion...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Where Abbott Laboratories Stands With Analysts
October 21, 2021
Over the past 3 months, 4 analysts have published their opinion on Abbott Laboratories (NYSE:
Via
Benzinga
10 Biggest Price Target Changes For Thursday
October 21, 2021
Wedbush boosted Tesla, Inc. (NASDAQ:TSLA) price ...
Via
Benzinga
3 Things Investors Should Love About Abbott's Q3 Results
October 21, 2021
There was nothing but good news for Abbott in Q3.
Via
The Motley Fool
Why Abbott Laboratories Shot Higher Today
October 20, 2021
All four of the company's divisions posted strong growth, but one in particular was a standout.
Via
The Motley Fool
Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
October 20, 2021
ABT earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abbot Labs and Biogen Outshine Novavax in the Health Care Sector
October 20, 2021
Just before Tuesday’s close, Netflix (NASDAQ: NFLX) reported better-than-expected earnings by adding 4.4 million subscribers in the third quarter. The company...
Via
Benzinga
A Crowded Earnings Calendar Ahead
October 20, 2021
Last week, major banks like Citigroup Inc (NYSE: C), The Goldman Sachs Group (NYSE: GS), and Bank of America Corporation (NYSE: BAC) have reported quarterly results with solid...
Via
Benzinga
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead
October 20, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 20, 2021 – USA News Group – It may have its beginning for the UK travel industry, but there are signs of the end of using...
Via
FinancialNewsMedia
Exposures
COVID-19
Abbott Labs Squashes Quarterly Views As Covid Testing Sales Pop
October 20, 2021
Abbott Laboratories reported $1.9 billion in sales of its Covid tests, rising sequentially.
Via
Investor's Business Daily
Abbott's Q3 Profit Jumps 70% On Robust COVID-19 Test Sales
October 20, 2021
Abbott Laboratories (NYSE: ABT) reported a 70.5% rise in quarterly profit to $2.1 billion, helped by strength in its medical devices and diagnostics businesses due...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Flat Ahead Of Earnings, Fed Minutes
October 20, 2021
Pre-open movers U.S. stock futures traded mostly flat in early pre-market trade after the Dow Jones climbed around 200 points in the previous session. Investors are awaiting...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
5 Stocks To Watch For October 20, 2021
October 20, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Verizon Communications Inc. (NYSE: VZ) to report quarterly earnings at $1.36 per share on revenue...
Via
Benzinga
Abbott Laboratories's Earnings Outlook
October 19, 2021
Abbott Laboratories(NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2021-10-20. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Neovasc Receives FDA Approval for COSIRA-II Clinical Trial
October 19, 2021
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Neovasc Inc. (...
Via
Benzinga
Exposures
Product Safety
Abbott and Real Madrid Team Up to Support the Health and Nutrition of Children Globally
October 19, 2021
SOURCE: Abbott
Via
3BL Media
Earnings Scheduled For October 20, 2021
October 20, 2021
Companies Reporting Before The Bell • Canadian Pacific Railway (NYSE:CP) is expected to report quarterly earnings at $0.95 per share on revenue of $2.02 billion....
Via
Benzinga
< Previous
1
2
...
31
32
33
34
35
36
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.